Hall 5, NEC, Birmingham, UK

20th & 21st May, 2026

NEC, Birmigham UK

20th & 21st May, 2026

Speaker:

Dr. Alaa Abdelkarim

Bio:

Dr. Alaa Abdelkarim, graduated from Cairo University medical school. He is Founder and Chief Medical Offi cer of ACE Cells Lab Limited, UK. He is a Consultant- endocrinology and stem cells therapy. He has more than 35 years of experience and served in more than 8 countries. He received Fellowship of Royal Society of Medicine, Royal Collage of Chemistry, Fellowship of the Malaysian Association of Endocrinology and the International association for stem cells research. He has been the head of department of endocrinology and diabetes for more than 8 years treating complications of diabetes by cellular applications. He has worked in the cell therapy since 2002 and headed the research department of cell therapy in many international labs. He is an international Lecturer in more than 20 countries. He has registered 20 patents in the fi eld of cell therapy and the protocols to extract the bioactive materials from live cells either autologous or from external sources (animal source). He is leading 2 multi-centre clinical trials in neurodegenerative disease, controlling the complications of diabetes mellitus type II by cellular applications. He is the Founder of ACE Factor deficiency theory which is considered as the new trend in regenerating tissues. With many publications and lectures in treating Multiple Sclerosis, Cerebral palsy and Amyotrophic lateral Sclerosis in different parts of the world he has supervised many master and PhD researches. Cuurenrly running clinical trial number NCT06787482 with title Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies (ACE Retino)

Sessions: